Search results
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 57 minutes agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 20 hours agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 20 hours agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after ...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 1 day agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 6 hours agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 21 hours agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 24 hours agoSome say the art of investing is the ability of catching falling knives. Pfizer Inc. (NYSE:PFE) shares have sold off in 2023 and represent an attractive...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 16 hours agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Flagship Pioneering and ProFound link for obesity therapies
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe collaboration marks the first initiative executed under Flagship’s Pioneering Medicines deal...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via Yahoo News· 17 hours agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...